Strategia terapeutica nella malattia avanzata Claudia Bighin Istituto Nazionale per la Ricerca sul Cancro Genova Roma, 19 Febbraio 2005.
Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy with Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of.
Optimizing Treatment for Her 2 Positive Metastatic Breast Cancer Patients Sunil Verma MD, MSEd, FRCPC Medical Oncologist Chair, Breast Medical Oncology.
